Pediatrics CertifiedShelley Crary, MD

Dr. Shelley Crary received her undergraduate degree in 1996 from Washington University in St. Louis, MO. She then attended medical school at Tulane University School of Medicine in New Orleans, LA. She completed Pediatrics residency at Vanderbilt University in 2003 and Pediatric Hematology-Oncology fellowship at University of Texas Southwestern Medical School in Dallas, TX in 2006. She also obtained a Master's Degree in Clinical Science in 2009 from UT Southwestern.

Dr. Crary joined the medical staff at ACH in 2011. She is board certified in both Pediatrics and Pediatric Hematology-Oncology.

Dr. Crary's primary clinical and research interests are focused on the care of children with bleeding or clotting disorders. She also has a strong interest in the hematologic aspects and medical management of complex vascular anomalies and works closely with the vascular anomalies multidisciplinary team at Arkansas Children's.

Dr. Crary is a pediatric hematologist who began her research career during her fellowship at University of Texas Southwestern Medical Center. Her research interests focus primarily on hemostasis—both bleeding and clotting disorders in children. She is currently involved in studies investigating novel oral anticoagulants in children as well as gene therapy for Hemophilia A and B. Dr. Crary has an interest in coagulopathy as it relates to patients with complex vascular malformations and is the principal investigator of a grant to establish a Vascular Anomaly Collaborative Research Program at ACH.

In addition to her hemostasis focus, Dr. Crary has also been involved in several studies of pediatric sickle cell disease. She is currently enrolling patients on a study of a novel drug to treat sickle cell pain crises.